The global beta glucan market size reached US$ 477.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 729.9 Million by 2028, exhibiting a growth rate (CAGR) of 7.64% during 2023-2028.
Beta-glucans are water-soluble dietary fibers found naturally in the cell walls of bacteria, fungi, yeasts, and various species of plants. They aid in lowering blood serum cholesterol, stimulating the immune system, regulating blood glucose levels, and reducing the risk of developing cardiovascular diseases (CVDs). As a result, they are widely used in medical supplements to help combat numerous health conditions, including eczema, diabetes, allergies, asthma, and heart disorders. Beta-glucans also assist in alleviating the symptoms of fibromyalgia, Crohn's disease, rheumatoid arthritis, ulcerative colitis, and chronic fatigue syndrome.
Beta Glucan Market Trends:
The rising prevalence of chronic diseases, in confluence with the growing preference for herbal medications, represents one of the key factors catalyzing the demand for beta-glucans. This can also be accredited to the increasing awareness among individuals about the benefits of beta-glucans, which include protecting against metabolic syndrome and obesity and decreasing fatigue caused by stress. Moreover, beta-glucans find application in boosting recovery among patients undergoing surgeries, using immunotherapy and other cancer treatments, or suffering from human immunodeficiency virus (HIV). In addition to this, the growing elderly population, which generally suffers from many comorbidities that often require multiple medications and surgical interventions, is contributing to the market growth. Apart from this, on account of their soothing, moisturizing, and anti-irritant properties, beta-glucans are utilized in personal care formulations, such as toothpaste, body cleaners, insect bite creams, and baby and shaving products. They are also added to sunscreens to provide protection from ultraviolet (UV) light exposure and redness of the skin. This, along with increasing consumer spending on personal care items due to improving income levels and rising concerns about personal grooming, is influencing the market positively.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global beta glucan market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, source and industry vertical.
Breakup by Type:
Breakup by Source:
Breakup by Industry Vertical:
- Animal Feed
- Personal Care and Cosmetics
Breakup by Region:
- North America
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being American International Chemical LLC (LeBaronBrown Industries LLC), Beta Bio Technology Sp Z O O, Ceapro Inc., Garuda International Inc., Kemin Industries Inc., Kerry Group plc, Koninklijke DSM N.V., Lallemand Inc., Lantmännen, Super Beta Glucan Inc., Tate & Lyle plc and Van Wankum Ingredients.
|Base Year of the Analysis
||Type, Source, Industry Vertical, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||American International Chemical LLC (LeBaronBrown Industries LLC), Beta Bio Technology Sp Z O O, Ceapro Inc., Garuda International Inc., Kemin Industries Inc., Kerry Group plc, Koninklijke DSM N.V., Lallemand Inc., Lantmännen, Super Beta Glucan Inc., Tate & Lyle plc and Van Wankum Ingredients
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)